A similar association between nuclear IGF-1R and worse outcomes has been reported in osteosarcomas [133], pediatric gliomas [134], synovial sarcomas [135], breast cancer [126], clear cell renal cell carcinoma [107], and embryonal rhabdomyosarcoma [136]. The gene discussed is IGF1R; the disease is osteosarcoma.